A comprehensive view of Johnson & Johnson Services Inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Consumer Wellness Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Johnson & Johnson Consumer Health to transition to all cornstarch-based baby powder products, will discontinue talc-based Johnson's Baby Powder globally in 2023; company maintains its talc-based baby powder does not contain asbestos, does not cause cancer
Published: August 12, 2022 by Johnson & Johnson Services Inc.
J&J files arbitration request alleging breach of contract by contract manufacturer Emergent Biosolutions in COVID-19 vaccination production dispute; Emergent claims J&J owes them US$420 for allegedly breaching their contract
Published: August 03, 2022 by FiercePharma
J&J converts 85% of US business to subcutaneous Darzalex Faspro cancer treatment from IV version; subcutaneous drug cuts treatment time from hours to minutes, had sales growth of US$1.8B in 2020 to US$3.8B for first half of 2022
Published: July 28, 2022 by FiercePharma
Johnson & Johnson Consumer Health launches Vivvi & Bloom, a new skin- and hair-care brand for babies and toddlers with millennial and Gen Z parents; initial products are wash and shampoo cleansing gel, face and body lotion, scalp and body massage oil
Published: July 27, 2022 by PR Newswire
Appellate branch of NY Supreme Court reverses lower court decision in talcum powder case against J&J, including US$120M damage claim; J&J argues its baby powder does not cause ovarian cancer
Published: July 25, 2022 by FiercePharma

Ask us about our Consumer Wellness market view

Trending Chart

Interactive chart with headline count